Wedbush Sees 64% Upside in Infleqtion with New Outperform Rating
Full neutral-atom quantum stack highlighted as a major advantage.
Already have an account? Sign in.
Full neutral-atom quantum stack highlighted as a major advantage.
Cencora reaffirms $17.75–$17.95 FY2026 EPS after minor Walgreens volume shift. Analysts see just 3–3.5% impact as core prime vendor deal stays intact.
LITE reports robust Q4, lifts guidance, and reaches long-term model early.
Quantinuum tops estimates in first public earnings, raises 2026 outlook, and partners with Oracle to deploy Helios quantum computer in the cloud.